Back
ProShares Ultra Nasdaq Biotechnology Vs. Xometry Industry Stock Comparison
Sell
50
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
64.10
Seasonality Move:
14.04%
Buy
60
XMTR
Xometry
Last Price:
30.62
Seasonality Move:
21.1%
Sell
50
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
Is ProShares Ultra Nasdaq Biotechnology a Buy, Sell or Hold?
- The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $64.31. The Score for BIB is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- BIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Xometry (XMTR)
is a Buy
Is Xometry a Buy, Sell or Hold?
- The current Xometry [XMTR] share price is $30.50. The Score for XMTR is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- XMTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BIB Stock Price Chart
What is ProShares Ultra Nasdaq Biotechnology's stock price today?
-
The ProShares Ultra Nasdaq Biotechnology share price today is $64.31
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIB is experiencing slight buying pressure.
BIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.31 | Sell |
| Relative Strength Index (14 RSI): | 55.47 | Buy |
| Chaikin Money Flow: | 680 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (61.29 - 64.17) | Buy |
| Bollinger Bands (100): | (60.67 - 66.55) | Buy |
XMTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.79 | Buy |
| Relative Strength Index (14 RSI): | 83.7 | Buy |
| Chaikin Money Flow: | 928620 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.1 - 22.94) | Buy |
| Bollinger Bands (100): | (13.47 - 20.35) | Buy |
BIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 62.39 | Buy |
| 20-day SMA: | 63.05 | Buy |
| 50-day SMA: | 63.92 | Buy |
| 200-day SMA: | 59.83 | Buy |
| 8-day EMA: | 62.7 | Buy |
| 20-day EMA: | 62.84 | Buy |
| 50-day EMA: | 63.29 | Buy |
| 200-day EMA: | 60.29 | Buy |
XMTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.57 | Buy |
| 20-day SMA: | 20.67 | Buy |
| 50-day SMA: | 19.35 | Buy |
| 200-day SMA: | 18.8 | Buy |
| 8-day EMA: | 23.81 | Buy |
| 20-day EMA: | 21.44 | Buy |
| 50-day EMA: | 19.55 | Buy |
| 200-day EMA: | 18.95 | Buy |
ProShares Ultra Nasdaq Biotechnology Earnings Growth & BIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Xometry Earnings Growth & XMTR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and an increase next year of $0.37 per share.
ProShares Ultra Nasdaq Biotechnology Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Xometry Technical Analysis
| Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||